KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Inventory Average (2016 - 2026)

Biocryst Pharmaceuticals filings provide 12 years of Inventory Average readings, the most recent being $5.3 million for Q4 2025.

  • On a quarterly basis, Inventory Average fell 32.07% to $5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 32.07% decrease, with the full-year FY2025 number at $6.7 million, down 63.33% from a year prior.
  • Inventory Average hit $5.3 million in Q4 2025 for Biocryst Pharmaceuticals, up from $5.1 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $29.2 million in Q1 2024 to a low of $5.1 million in Q3 2025.
  • Median Inventory Average over the past 5 years was $15.3 million (2021), compared with a mean of $16.2 million.
  • Biggest five-year swings in Inventory Average: soared 162.8% in 2022 and later tumbled 78.8% in 2024.
  • Biocryst Pharmaceuticals' Inventory Average stood at $14.7 million in 2021, then soared by 85.21% to $27.3 million in 2022, then increased by 6.89% to $29.2 million in 2023, then crashed by 73.16% to $7.8 million in 2024, then plummeted by 32.07% to $5.3 million in 2025.
  • The last three reported values for Inventory Average were $5.3 million (Q4 2025), $5.1 million (Q3 2025), and $6.0 million (Q2 2025) per Business Quant data.